Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Amgen, Servier heart failure drug clears trial hurdle

Amgen, Servier heart failure drug clears trial hurdle

than Novartis’ Entresto (sacubitril/valsartan) and Amgen/Servier's Corlanor (ivabradine), which were both approved for heart failure in 2015.

New faces at 11 London, ramarketing and MSL

New faces at 11 London, ramarketing and MSL such as UCB, GSK and Novartis.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m The Cambridge, Mass-based company is joining an increasingly crowded market of innovative therapies for hard-to-treat blood disorders such as SCD, where Novartis and gene therapy company Bluebird already ... Novartis is also making waves in the area

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation industry. Recent examples of this include rapid pricing deals on the two CAR-T therapies, Novartis’ Kymriah and Gilead’s Yescarta. ... This includes cell and gene therapies such as Novartis’ late-stage candidate Zolgensma, which the company has

Francis exits Sandoz, reigniting spinoff rumours

Francis exits Sandoz, reigniting spinoff rumours He has been with Novartis for 25 years and Vas Narasimhan said Balestrieri would continue Sandoz's transformation. ... Analysts think the sale could raise $15-23bn for Novartis, which has already planned a $5bn share buyback after the sale.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics